Company Filing History:
Years Active: 2022
Title: Ulrich-Peter Rohr: Innovator in Colorectal Cancer Therapy Prediction
Introduction
Ulrich-Peter Rohr is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of medical technology, particularly in the area of cancer treatment. His innovative approach focuses on improving patient outcomes through advanced diagnostic methods.
Latest Patents
Ulrich-Peter Rohr holds a patent for a non-invasive test designed to predict the response to therapy in colorectal cancer patients. This groundbreaking invention involves the analysis of circulating tumor DNA from a patient's sample, providing valuable insights into the effectiveness of treatment options.
Career Highlights
Throughout his career, Ulrich-Peter Rohr has worked with prominent companies in the medical field. He has been associated with Roche Sequencing Solutions, Inc. and Ventana Medical Systems, Inc., where he has contributed to the development of cutting-edge technologies aimed at enhancing cancer diagnostics and treatment.
Collaborations
Ulrich-Peter Rohr has collaborated with talented professionals in his field, including John Lee and Alexander Lovejoy. These partnerships have fostered innovation and have played a crucial role in advancing research and development in cancer therapy.
Conclusion
Ulrich-Peter Rohr's work exemplifies the impact of innovation in healthcare, particularly in the realm of cancer treatment. His contributions continue to influence the way therapies are tailored to individual patients, ultimately improving their chances of successful outcomes.